Wararka | Faafida Coronavirus
7 Dec 2021″ SOURCE: REUTERS
Daraasadda jaamacadda Oxford waxay ogaatay in lagu qaso qiyaasta koowaad ee tallaalka Pfizer ama Astrazeneca oo leh tallaalka Moderna ee labaad ay dhaliso difaaca jirka sare.
Wadamo badan ayaa si fiican u daabulayey qaab isku dhafan iyo ciyaar ka hor inta aan la helin xog adag ()
Darnaanta Omicron:
Warbixinno hore oo ka soo baxay dhakha壯陽藥 atiirta Koonfur Afrika ayaa sheegaya in kiisaska kala duwan ee Omicron guud ahaan ay fudud yihiin, laakiin khubarada caalamku waxa ay ka digayaan in ay aad goor hore tahay in la ogaado khatarta ay leedahay.
Faafitaanka bulshada: England waxay ogaatay gudbinta bulshada ee nooca Omicron sida liiska sii kordhaya ee wadamada ay ka warbixiyaan kiisaska isa soo taraya.
France liiska cas: Xarumaha The US for Xakamaynta iyo Kahortagga Cudurrada ayaa shan meelaha Yurub – oo ay ku jiraan France – on liiska meelaha halista Covid-19 safarka “mid aad u sarreeya”.
Daraasad Ingiriis ah oo weyn oo lagu isku darayo tallaallada COVID-19 ayaa lagu ogaaday in dadku ay heleen jawaab celin ka wanaagsan markii ay heleen tallaalada AstraZeneca ama Pfizer-BioNTech oo ay ku xigto Moderna sagaal toddobaad ka dib, marka loo eego natiijooyinka.
“Waxaan ka helnay jawaab celin difaac oo wanaagsan guud ahaan guddiga… dhab ahaantii, ka sarreeya heerka uu dhigay tallaalka Oxford-AstraZeneca laba qiyaasood,” Matthew Snape, borofisar Oxford ah oo ka dambeeya tijaabada Com-COV2, ayaa u sheegay wakaaladda wararka ee Reuters Isniintii.
Natiijooyinka taageeraya qiyaasta dabacsanaanta waxay siin doontaa xoogaa rajo ah waddamada dakhligoodu hooseeyo iyo kuwa dhexdhexaadka ah ee laga yaabo inay u baahdaan inay isku daraan tallaallada qiyaasaha koowaad iyo labaad haddii sahaydu hoos u dhacdo ama ay xasilloonaato.
“Waxaan u maleynayaa in xogta laga helay daraasaddan ay si gaar ah u xiiso badan tahay oo qiimo u yeelan doonto waddamada dakhligoodu hooseeyo iyo kuwa dhexdhexaadka ah halkaas oo ay weli soo saarayaan labada qiyaasood ee ugu horreeya ee tallaallada,” ayuu yiri Snape.
“Waxaan tusineynaa… uma baahnid inaad si adag ugu adkaysato qaadashada tallaalka isku midka ah ee qiyaasta labaad…
Haddii tallaalka AstraZeneca-Oxford uu raaco tallaalka Moderna ama Novavax, unugyada difaaca jirka oo sarreeya iyo jawaabaha unugyada T-unugga ayaa lagu soo rogay laba qiyaasood oo AstraZeneca-Oxford ah, sida ay sheegeen cilmi-baarayaasha Jaamacadda Oxford.
Daraasadda 1,070 mutadawiciin ah ayaa sidoo kale lagu ogaaday in qiyaasta tallaalka Pfizer-BioNTech oo ay ku xigto tallaalka Moderna ay ka wanaagsan tahay laba qiyaasood oo Pfizer-BioNTech ah.
Pfizer-BioNTech oo ay ku xigto Novavax waxay keentay unugyada difaaca jirka ka sarreeya marka loo eego jadwalka labada-qiyaas ee Oxford-AstraZeneca, in kasta oo jadwalkani uu keenay jawaabaha antibody hoose iyo unugyada T-unugga marka loo eego jadwalka laba-qiyaas ee Pfizer-BioNTech.
Ma jiro wax walaac ah oo xagga ammaanka ah oo la soo qaaday, sida laga soo xigtay daraasadda jaamacadda Oxford ee lagu daabacay joornaalka caafimaadka ee Lancet.
Wadamo badan ayaa si fiican u daabulayay hab isku dhafan ka hor inta aan la helin xog adag maadaama ay wajaheen tirooyinka caabuqa ee sii kordhaya, sahayda oo yar iyo tallaal gaabis ah sababo la xiriira amniga qaarkood.
Muddada dheer ee ilaalinta ay bixiyaan tallaaladu waa la baaray, iyada oo qiyaasaha xoojiyaha la tixgeliyey iyo sidoo kale xaaladaha sii kordhaya. Helitaanka noocyo cusub, oo ay ku jiraan Delta iyo Omicron, ayaa kordhisay cadaadiska lagu dardargelinayo ololaha tallaalka.
Daraasadda waxaa loogu talagalay sida loogu yeero daraasadda “aan-hooseeya” – ujeedadu waa in la muujiyo in isku-darka aysan si weyn uga xumaanin jadwalka caadiga ah – oo isbarbardhigga jawaabaha habka difaaca ee jawaabaha heerka dahabiga ah ee lagu soo warramey tijaabooyin hore oo caafimaad tallaal kasta.
Si gooni gooni ah Isniintii, Ururka Caafimaadka Adduunka wuxuu ku taliyay inaan la isticmaalin balasmaha dhiigga bukaannada ka soo kabsaday COVID-19 si loogu daweeyo kuwa buka, iyadoo sheegtay in caddaynta hadda jirta ay muujinayso inaysan hagaajinaynin badbaadada mana yarayso baahida hawo-mareenada.
Habka ayaa sidoo kale kharash badan iyo waqti badan ku qaadata maamulka, WHO ayaa bayaan ku sheegtay.
Mala-awaalka isticmaalka balaasmaha ayaa ah in unugyada difaaca jirka ee ay ku jiraan ay ka joojin karaan coronavirus-ga cusub inuu soo koobo oo uu joojiyo dhaawaca unugyada. Daraasado dhowr ah oo lagu baaray plasma convalescent blood plasma ma muujin wax faa’iido muuqata ah oo loogu talagalay daawaynta bukaannada COVID-19 ee aadka u xanuunsan.
Saynis yahanadu waxay carrabka ku adkeeyeen inay goor hore tahay in la sameeyo go’aano adag oo ku saabsan darnaanta Omicron coronavirus kala duwanaanshaha, iyo khubarada caafimaadku waxay dadka ku dhiirigelinayaan inay iska tallaalaan Covid-19, iyo sidoo kale inay qaataan taxaddarro kale.
Hase yeeshe – halka kala duwanaanshaha cusubi u muuqdo inuu si dhakhso ah u faafo – waxaa jira caddayn dhiirigelin leh xogta hore ee Koonfur Afrika, taas oo soo jeedinaysa in kiisaska ‘Covid-19’ ee uu sababay Omicron ay noqon karaan kuwo khafiif ah.
Dr. Salim Abdool Karim, oo ah khabiir ku takhasusay cudurrada faafa isla markaana xubin ka ah guddiga hawlgelinta Afrika ee Coronavirus, ayaa CNN u sheegay Isniintii in dhakhaatiirta daawaynaysa bukaannada Omicron ay sheegeen in ay arkeen caabuqyo guud ahaan khafiif ah.
“Qofku waa inuu aad uga taxaddaraa in si xad dhaaf ah loo tarjumo sababtoo ah weli waa maalmo aad u horeeysa kiisaskaas daran, waad ogtahay, badanaa waxay qaataan waqti dheer, waxay ku dhacaan toddobaadyo laba, saddex iyo afar,” ayuu raaciyay.
Dhanka kale, Omicron ayaa wali ku faafaya adduunka oo dhan, dalal badanna waxay sii wadaan dagaalka ay kula jiraan kala duwanaanshaha Delta. Tan waxaa ku jira Mareykanka, kaasoo soo sheegaya 120,000 oo kiis oo cusub oo ah Covid-19 maalin kasta, sida ay sheegtay jaamacadda Johns Hopkins.
XIGASHO: REUTERS